Can CYP2C19 help with Haut?

CYP2C19 is primarily a drug-metabolizing enzyme (e.g., for clopidogrel, proton pump inhibitors, antidepressants). There is no robust evidence that CYP2C19 directly influences skin health. Some mechanistic studies suggest variants may affect the metabolism of certain dermatological drugs or contribute to adverse reactions, but this is not a validated biomarker for common skin conditions like acne, eczema, or aging. Consumer DNA tests that market CYP2C19 as a 'skin gene' overstate the science. For skin concerns, factors such as UV exposure, skin type, diet, microbiome, and clinical assessment are far more relevant. A genetic test alone cannot guide personalized skincare or therapy. Evidence: mechanistic/unclear. Safety note: CYP2C19 status is relevant for drug dosing, but not for general skin recommendations.